The Department of Otolaryngology – Head and Neck Surgery, in conjunction with the Penn State Cancer Institute, participates in many clinical trials.
Current Studies
-
- Treating Obstructive Sleep Apnea using Targeted Hypoglossal Nerve Stimulation – The OSPREY Study
- Site for A Randomized Phase II/III Trial of De-intensified Radiation Therapy for Patients with Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
- Site For Randomized Phase II/III Trial Of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection For Early-Stage Oral Cavity Cancer
- Site for Randomized Phase II/III Trial of Radiation with High-Dose Cisplatin (100 mg/m2) Every Three Weeks versus Radiation with Low-Dose Weekly Cisplatin (40 mg/m2) for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
- Site for Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
- Keystroke: A Randomized Phase Ii Study Of Pembrolizumab (Keytruda®) Plus Stereotactic Re-Irradiation Versus Sbrt Alone For Locoregionally Recurrent Or Second Primary Head And Neck Carcinoma
- A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab versus Placebo after Surgery and Radiation Therapy in Patients with High Risk Cutaneous Squamous Cell Carcinoma
- A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab versus Placebo after Surgery and Radiation Therapy in Patients with High Risk Cutaneous Squamous Cell Carcinoma
View all active trials on StudyFinder.
Learn More About Clinical Research
- Read our clinical research FAQs
- Become a healthy volunteer
- See latest Penn State Health and Penn State College of Medicine clinical research news
Contact Us
For details on current studies, contact Caia Hypatia at 717-531-0003 x287291or chypatia@pennstatehealth.psu.edu.